MA183743
Influenza A H3N2 Monoclonal Antibody (30-2F11-F7-A5), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MA183743-Each-of-1 | In Stock | ₹ 80,100.00 |
MA183743 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 80,100.00
GST (18%): ₹ 14,418.00
Total Price: ₹ 94,518.00
Antigen
Influenza A H3N2
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.1% sodium azide
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG2a
Applications
Immunocytochemistry
Clone
30-2F11-F7-A5
Conjugate
Unconjugated
Gene Alias
H3N2; Influenza H3N2
Immunogen
Influenza blend
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- MA1-83743 is specific for influenza A H3 antigen
- This antibody may not react with all H3N2 Influenza A strains: it reacts strongly with the A/Shainghai/11/87 strain, but shows no reactivity with the A/Wuhan/359/95 strain
- Mouse anti Influenza A H3 antigen antibody, clone 30-2F11-F7-A5recognizes the Influenza A H3 antigen and shows no reactivity to influenza B strains
- Influenza viruses consists of three types (Influenza A, B, and C), which make up three of the five genera in the Orthomyxoviridae family
- Commonly know as the flu, influenza strains can affect both birds and mammals
- Influenza strains form roughly spherical particles and are similar in composition with viral envelope containing two main types of glycoproteins (hemagglutinin and neuraminidase), wrapped around the central core of the viral RNA genome and other viral proteins that package and protect the RNA
- Unusually for a virus, the influenzavirus genome is not a single piece of nucleic acid; rather a seven to eight segmented fragments of negative-sense RNA with each fragment expressing different viral proteins
- Influenza spreads seasonally, resulting in about three to five million yearly cases of severe illness and about 250,000 to 500,000 deaths annually or into the millions in pandemic years.